Plasma components: properties, differences, and uses

Anaphylactic reaction after methylene blue-treated plasma transfusion

(2011) P. Dewachter et al.   BRITISH JOURNAL OF ANAESTHESIA

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2years at −30°C

(2011) Anna Ettinger et al.   TRANSFUSION AND APHERESIS SCIENCE

Inactivation photochimique des pathogènes des plaquettes et du plasma : cinq ans d’utilisation clinique de routine et d’hémovigilance. Vers un changement de paradigme de la sécurité en transfusion

(2011) J.-P. Cazenave   TRANSFUSION CLINIQUE ET BIOLOGIQUE

Sources of variation in factor VIII, von Willebrand factor and fibrinogen measurements: Implications for detecting deficiencies and increased plasma levels

(2010) Juergen Bach et al.   THROMBOSIS RESEARCH

Facilitating blood component preparation: the impact of overnight room temperature storage

(2010)   TRANSFUSION

An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment

(2010) Jean-Pierre Cazenave et al.   TRANSFUSION

A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States

(2010) Steven Kleinman et al.   TRANSFUSION

Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008)

(2010) Anne F. Eder et al.   TRANSFUSION

Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue

(2010) Karine Nubret et al.   TRANSFUSION

Ambient overnight hold of whole blood prior to the manufacture of blood components

(2010) Stephen Thomas   TRANSFUSION MEDICINE

A comparison of methods of pathogen inactivation of FFP

(2010) G. Rock   VOX SANGUINIS

Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats

(2009) Vic Ciaravino et al.   TRANSFUSION

Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards

(2009) Katherine Serrano et al.   TRANSFUSION

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

(2009) James Smith et al.   TRANSFUSION

Properties of Pathogen-Inactivated Plasma Components

(2009) Christopher Prowse   TRANSFUSION MEDICINE REVIEWS

Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at −30°C

(2009) D. J. Bihm et al.   VOX SANGUINIS

Methylene blue-photoinactivated plasmaversusquarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study

(2008) Julio del Río-Garma et al.   BRITISH JOURNAL OF HAEMATOLOGY

ADAMTS-13 activity and von Willebrand factor levels in methylene blue photo-inactivated plasma processed by either the Springe method or an in house system

(2008) J. del Ro-Garma et al.   VOX SANGUINIS